Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment?
The aim of the present study was to evaluate the prognostic value of classical risk factors in chronic heart failure (CHF) since introduction of routine β-blocker treatment in CHF.
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
01 September 2001
|
| In: |
European heart journal
Year: 2001, Volume: 22, Pages: 300 |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/22.Abstract_Supplement.1 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/22/Abstract_Supplement/1/466328 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article-pdf/22/Abstract_Supplement/1/1265128/22-Abstract_Supplement-1.pdf |
| Author Notes: | C. Zugck, R. Kell, A. Kirschke, D. Schellberg, D. Lossnitzer, M. Haass, A. Haunstetter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1757696229 | ||
| 003 | DE-627 | ||
| 005 | 20220819203424.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210512s2001 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/eurheartj/22.Abstract_Supplement.1 |2 doi | |
| 035 | |a (DE-627)1757696229 | ||
| 035 | |a (DE-599)KXP1757696229 | ||
| 035 | |a (OCoLC)1341409040 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zugck, Christian |e VerfasserIn |0 (DE-588)1028371993 |0 (DE-627)730617548 |0 (DE-576)176412999 |4 aut | |
| 245 | 1 | 0 | |a Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment? |c C. Zugck, R. Kell, A. Kirschke, D. Schellberg, D. Lossnitzer, M. Haass, A. Haunstetter |
| 246 | 3 | 0 | |a β beta blocker |
| 246 | 3 | 3 | |a Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of beta-blocker treatment? |
| 264 | 1 | |c 01 September 2001 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.05.2021 | ||
| 520 | |a The aim of the present study was to evaluate the prognostic value of classical risk factors in chronic heart failure (CHF) since introduction of routine β-blocker treatment in CHF. | ||
| 700 | 1 | |a Kell, Robert |d 1970- |e VerfasserIn |0 (DE-588)124009131 |0 (DE-627)706507010 |0 (DE-576)293979685 |4 aut | |
| 700 | 1 | |a Kirschke, Andreas Erich |d 1974- |e VerfasserIn |0 (DE-588)124445586 |0 (DE-627)363353550 |0 (DE-576)294175555 |4 aut | |
| 700 | 1 | |a Schellberg, Dieter |e VerfasserIn |0 (DE-588)1028373023 |0 (DE-627)730619974 |0 (DE-576)375906010 |4 aut | |
| 700 | 1 | |a Loßnitzer, Dirk |d 1972- |e VerfasserIn |0 (DE-588)124754031 |0 (DE-627)365721506 |0 (DE-576)29448325X |4 aut | |
| 700 | 1 | |a Haass, Markus |e VerfasserIn |0 (DE-588)140599282 |0 (DE-627)620224517 |0 (DE-576)319037940 |4 aut | |
| 700 | 1 | |a Haunstetter, Armin |e VerfasserIn |0 (DE-588)1052546978 |0 (DE-627)788604570 |0 (DE-576)408318139 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European heart journal |d Oxford : Oxford University Press, 1980 |g 22(2001), Abstract_Supplement, Artikel-ID P1644, Seite 300 |h Online-Ressource |w (DE-627)320415813 |w (DE-600)2001908-7 |w (DE-576)103746846 |x 1522-9645 |7 nnas |a Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment? |
| 773 | 1 | 8 | |g volume:22 |g year:2001 |g supplement:Abstract_Supplement |g elocationid:P1644 |g pages:300 |g extent:1 |a Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment? |
| 856 | 4 | 0 | |u https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/eurheartj/article/22/Abstract_Supplement/1/466328 |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/eurheartj/article-pdf/22/Abstract_Supplement/1/1265128/22-Abstract_Supplement-1.pdf |q application/pdf |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210512 | ||
| 993 | |a Article | ||
| 994 | |a 2001 | ||
| 998 | |g 1052546978 |a Haunstetter, Armin |m 1052546978:Haunstetter, Armin |d 50000 |e 50000PH1052546978 |k 0/50000/ |p 7 |y j | ||
| 998 | |g 140599282 |a Haass, Markus |m 140599282:Haass, Markus |d 50000 |e 50000PH140599282 |k 0/50000/ |p 6 | ||
| 998 | |g 124754031 |a Loßnitzer, Dirk |m 124754031:Loßnitzer, Dirk |d 50000 |e 50000PL124754031 |k 0/50000/ |p 5 | ||
| 998 | |g 1028373023 |a Schellberg, Dieter |m 1028373023:Schellberg, Dieter |d 910000 |d 910100 |e 910000PS1028373023 |e 910100PS1028373023 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 124445586 |a Kirschke, Andreas Erich |m 124445586:Kirschke, Andreas Erich |d 50000 |e 50000PK124445586 |k 0/50000/ |p 3 | ||
| 998 | |g 124009131 |a Kell, Robert |m 124009131:Kell, Robert |d 50000 |e 50000PK124009131 |k 0/50000/ |p 2 | ||
| 998 | |g 1028371993 |a Zugck, Christian |m 1028371993:Zugck, Christian |d 910000 |d 910100 |e 910000PZ1028371993 |e 910100PZ1028371993 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1757696229 |e 3927612146 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1757696229","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 12.05.2021"],"titleAlt":[{"title":"Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of beta-blocker treatment?"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Zugck, Christian","given":"Christian","family":"Zugck"},{"family":"Kell","given":"Robert","display":"Kell, Robert","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Kirschke","given":"Andreas Erich","roleDisplay":"VerfasserIn","display":"Kirschke, Andreas Erich","role":"aut"},{"family":"Schellberg","given":"Dieter","display":"Schellberg, Dieter","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Dirk","family":"Loßnitzer","role":"aut","roleDisplay":"VerfasserIn","display":"Loßnitzer, Dirk"},{"display":"Haass, Markus","roleDisplay":"VerfasserIn","role":"aut","family":"Haass","given":"Markus"},{"role":"aut","display":"Haunstetter, Armin","roleDisplay":"VerfasserIn","given":"Armin","family":"Haunstetter"}],"title":[{"title":"Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment?","title_sort":"Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment?"}],"relHost":[{"pubHistory":["1.1980 -"],"part":{"pages":"300","year":"2001","extent":"1","volume":"22","text":"22(2001), Abstract_Supplement, Artikel-ID P1644, Seite 300"},"disp":"Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment?European heart journal","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 12.09.2017"],"recId":"320415813","language":["eng"],"title":[{"title_sort":"European heart journal","title":"European heart journal"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1980","publisher":"Oxford University Press ; Harcourt","dateIssuedDisp":"1980-","publisherPlace":"Oxford ; London [u.a.]"}],"id":{"issn":["1522-9645"],"eki":["320415813"],"zdb":["2001908-7"]}}],"physDesc":[{"extent":"1 S."}],"name":{"displayForm":["C. Zugck, R. Kell, A. Kirschke, D. Schellberg, D. Lossnitzer, M. Haass, A. Haunstetter"]},"id":{"eki":["1757696229"],"doi":["10.1093/eurheartj/22.Abstract_Supplement.1"]},"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"01 September 2001"}]} | ||
| SRT | |a ZUGCKCHRISDOWEHAVETO0120 | ||